Evi Lianidou, Ph.D.

Professor of Analytical Chemistry – Clinical Chemistry
Laboratory of Analytical Chemistry
Analysis of Circulating Tumor Cells (ACTC) Lab
Dept of Chemistry
National and Kapodistrian University of Athens
Athens, Greece
email: lianidou@chem.uoa.gr, evilianidou@gmail.com
Website: en.actc-lab.chem.uoa.gr

 Short Summary

Dr. Evi Lianidou is Professor of Analytical Chemistry and Clinical Chemistry at the Department of Chemistry, University of Athens, Greece.  Dr Lianidou has established a Molecular Diagnostics Laboratory focused on Liquid Biopsy at the Department of Chemistry in 1998 (http://en.actc-lab.chem.uoa.gr/). Prof Lianidou’s lab is specializing in the Liquid Biopsy Analysis, Analysis of Circulating Tumor Cells (ACTC) and cell-free DNA, and has access to many patient samples through extensive clinical collaborations. Her main research interests are on the development and clinical evaluation of: a) RNA-based assays for gene expression in CTCs, using RT-qPCR, RT-ddPCR and liquid bead arrays, b) DNA mutations in CTCs and ctDNA using ultrasensitive multiplex ddPCR, c) DNA methylation assays in CTCs and ctDNA using MSP and ddPCR, and d) analysis of cf-miRNAs.

Dr. Lianidou has organized the following international meetings on liquid biopsy:  

1. ACTC2012:http://actc2012.chem.uoa.gr/actc2012.org.144-76-185-131.winzone45.grserver.gr/index.html
2. ACTC2014:http://actc2014.chem.uoa.gr/www.actc2014.org/index.html
3. ACTC2017: http://actc2017.chem.uoa.gr/actc2017.org/index.html
4. ACTC2019: http://actc2019.chem.uoa.gr/actc2019.org/index.html
5. ACTC2021: https://www.erasmus.gr/microsites/1206
6. ACTC2023: https://www.erasmus.gr/microsites/1261
7. ACTC2025: www.actc2025.org

Prof Lianidou was PI in many EU funded projects including the IMI “CANCER-ID” (www.cancer-id.eu). Dr Lianidou is an elected Board member of the European Association of Cancer Research (EACR) (https://www.eacr.org/governance/board), a member of the European Liquid Biopsy Society https://www.uke.de/english/departments-institutes/institutes/tumor-biology/european-liquid-biopsy-society-elbs/working-groups/index.html, a member of the International Society of Liquid Biopsy (ISLB) and serves on the Editorial Boards of many international journals. Dr. Lianidou served International Federation of Clinical Chemistry (IFCC) as an elected member and Chair of the Committee for Clinical Molecular Biology Curriculum (2014-2019, (http://www.ifcc.org/ifcc-education-division/emd-committees/c-cmbc/).

Prof. Lianidou holds the following patents on liquid biopsy tests: 1) Development of a quantitative real-time RT-PCR assay for CK-19 mRNA expression: circulating tumor cells in peripheral blood (CTCs), (CE, IVD test). Inventors: Lianidou E, Stathopoulou A., Mavroudis D., Georgoulias V. http://www.freepatentsonline.com/y2010/0015604.html, 2) Method of determining PIK3CA mutational status in a sample.  (CE, IVD test). Inventors: Lianidou E, Markou A. http://www.freepatentsonline.com/WO2016020710A1.html, 3) Method for the quantification of PD-L1 expression. (CE, IVD test). Inventors: Lianidou E, Strati A. http://www.freepatentsonline.com/WO2017072539A1.html.

BOOK EDITOR: R.J.Cote, E. Lianidou, Editors: “Circulating Tumor Cells, Advances in Liquid Biopsy Technologies”, Springer, Current Cancer Research Series, 2nd Edition, 2023, ISBN 978-3-031-22902-2, https://doi.org/10.1007/978-3-031-22903-9.

Publications: 192 (https://pubmed.ncbi.nlm.nih.gov/?term=+lianidou&sort=date)

h-index: 63, i10-index: 156, citations: 12088.

Google scholar: https://scholar.google.gr/citations?user=gvx_1p0AAAAJ&hl=en)